149 related articles for article (PubMed ID: 10092985)
1. The effect of circulating non-esterified fatty acids on the entero-insular axis.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Eur J Clin Invest; 1999 Jan; 29(1):27-32. PubMed ID: 10092985
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of carbohydrate-mediated glucagon-like peptide-1 (7-36)amide secretion by circulating non-esterified fatty acids.
Ranganath L; Norris F; Morgan L; Wright J; Marks V
Clin Sci (Lond); 1999 Apr; 96(4):335-42. PubMed ID: 10087239
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of insulin, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) secretion by octreotide has no effect on post-heparin plasma lipoprotein lipase activity.
Ranganath LR; Beety JM; Morgan LM
Horm Metab Res; 1999 Apr; 31(4):262-6. PubMed ID: 10333081
[TBL] [Abstract][Full Text] [Related]
4. Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1).
Ranganath L; Schaper F; Gama R; Morgan L; Wright J; Teale D; Marks V
Diabetes Metab Res Rev; 1999; 15(6):390-4. PubMed ID: 10634963
[TBL] [Abstract][Full Text] [Related]
5. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
6. Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects.
Ranganath LR; Beety JM; Wright J; Morgan LM
Horm Metab Res; 2001 Jan; 33(1):57-61. PubMed ID: 11280717
[TBL] [Abstract][Full Text] [Related]
7. Postprandial hormone and metabolic responses in simulated shift work.
Hampton SM; Morgan LM; Lawrence N; Anastasiadou T; Norris F; Deacon S; Ribeiro D; Arendt J
J Endocrinol; 1996 Nov; 151(2):259-67. PubMed ID: 8958786
[TBL] [Abstract][Full Text] [Related]
8. The ageing entero-insular axis.
Ranganath L; Sedgwick I; Morgan L; Wright J; Marks V
Diabetologia; 1998 Nov; 41(11):1309-13. PubMed ID: 9833938
[TBL] [Abstract][Full Text] [Related]
9. Attenuated GLP-1 secretion in obesity: cause or consequence?
Ranganath LR; Beety JM; Morgan LM; Wright JW; Howland R; Marks V
Gut; 1996 Jun; 38(6):916-9. PubMed ID: 8984033
[TBL] [Abstract][Full Text] [Related]
10. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
11. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 (7-36)amide and glucose-dependent insulinotropic polypeptide secretion in response to nutrient ingestion in man: acute post-prandial and 24-h secretion patterns.
Elliott RM; Morgan LM; Tredger JA; Deacon S; Wright J; Marks V
J Endocrinol; 1993 Jul; 138(1):159-66. PubMed ID: 7852887
[TBL] [Abstract][Full Text] [Related]
13. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
14. Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance.
Rask E; Olsson T; Söderberg S; Holst Jj Jj; Tura A; Pacini G; Ahrén B
Metabolism; 2004 May; 53(5):624-31. PubMed ID: 15131768
[TBL] [Abstract][Full Text] [Related]
15. Glucose-dependent insulinotropic polypeptide and insulin-like immunoreactivity in saliva following sham-fed and swallowed meals.
Messenger B; Clifford MN; Morgan LM
J Endocrinol; 2003 Jun; 177(3):407-12. PubMed ID: 12773121
[TBL] [Abstract][Full Text] [Related]
16. Entero-insular axis in children with anorexia nervosa.
Tomasik PJ; Sztefko K; Starzyk J; Rogatko I; Szafran Z
Psychoneuroendocrinology; 2005 May; 30(4):364-72. PubMed ID: 15694116
[TBL] [Abstract][Full Text] [Related]
17. Effects of acute NEFA manipulation on incretin-induced insulin secretion in participants with and without type 2 diabetes.
Astiarraga B; Chueire VB; Souza AL; Pereira-Moreira R; Monte Alegre S; Natali A; Tura A; Mari A; Ferrannini E; Muscelli E
Diabetologia; 2018 Aug; 61(8):1829-1837. PubMed ID: 29732475
[TBL] [Abstract][Full Text] [Related]
18. Incretin and islet hormonal responses to fat and protein ingestion in healthy men.
Carr RD; Larsen MO; Winzell MS; Jelic K; Lindgren O; Deacon CF; Ahrén B
Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E779-84. PubMed ID: 18612044
[TBL] [Abstract][Full Text] [Related]
19. The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction.
Verdich C; Toubro S; Buemann B; Lysgård Madsen J; Juul Holst J; Astrup A
Int J Obes Relat Metab Disord; 2001 Aug; 25(8):1206-14. PubMed ID: 11477506
[TBL] [Abstract][Full Text] [Related]
20. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.
Fukase N; Igarashi M; Takahashi H; Manaka H; Yamatani K; Daimon M; Tominaga M; Sasaki H
Diabet Med; 1993; 10(1):44-9. PubMed ID: 8435987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
